Contribution of classical end-joining to PTEN inactivation in p53-mediated glioblastoma formation and drug-resistant survival
We know that defects in DNA repair genes are associated with cancer development. Here the authors eliminate XRCC4, a non-homologous end-joining protein, and p53 in the developing brain and find that this causes glioblastoma development as a consequence of reduced PTEN function.
Saved in:
Main Authors: | Youn-Jung Kang, Barbara Balter, Eva Csizmadia, Brian Haas, Himanshu Sharma, Roderick Bronson, Catherine T. Yan |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/f33589217b7d48c4b64850b9eada2abb |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Corrigendum: Contribution of classical end-joining to PTEN inactivation in p53-mediated glioblastoma formation and drug-resistant survival
by: Youn-Jung Kang, et al.
Published: (2017) -
Causes and Effects of Loss of Classical Nonhomologous End Joining Pathway in Parasitic Eukaryotes
by: Anna Nenarokova, et al.
Published: (2019) -
WRN regulates pathway choice between classical and alternative non-homologous end joining
by: Raghavendra A. Shamanna, et al.
Published: (2016) -
BRCA2 antagonizes classical and alternative nonhomologous end-joining to prevent gross genomic instability
by: Jinhua Han, et al.
Published: (2017) -
Involvement of classic and alternative non-homologous end joining pathways in hematologic malignancies: targeting strategies for treatment
by: Mohsen Valikhani, et al.
Published: (2021)